2pnu

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The androgen receptor (AR) mediates the action of androgens in normal, conditions as well as in pathological states. Antiandrogens are thus, commonly used to treat androgen-dependent disorders. The currently used, drugs unfortunately possess very weak affinity for the human AR (hAR), thus indicating the need to develop new high-affinity steroidal, antiandrogens. Our compounds are specially designed to impede, repositioning of the mobile carboxy-terminal helix 12, which blocks the, ligand-dependant transactivation function (AF-2) located in the AR, ligand-binding domain (ARLBD). Using crystal structures of the hARLBD, we, first found that H12 could be directly reached from the ligand-binding, pocket (LBP) by a chain positioned on the C18 atom of an androgen steroid, nucleus. A set of DHT-derived molecules bearing various C18 chains were, thus synthesized and tested for their capacity to bind hAR and act as, antagonists. Although most of those having very high affinity for hAR were, agonists, several very potent antagonists were obtained, confirming the, structural importance of the C18 chain. To understand the role of the C18, chain in their agonistic/antagonistic properties, the structure of the, hARLBD complexed with one of these agonists, EM5744, was determined at a, 1.65 A resolution. We have identified new interactions involving Gln738, Met742 and His874 that explain both the high-affinity of this compound and, the inability of its bulky chain to prevent the repositioning of H12., These structural informations will be helpful to refine the structure of, the chains placed on the C18 atom in order to obtain efficient, H12-directed steroidal antiandrogens.
+
Antiandrogens are commonly used to treat androgen-dependent disorders. The currently used drugs unfortunately possess very weak affinity for the human AR (hAR), thus indicating the need to develop new high-affinity steroidal antiandrogens. Our compounds are specially designed to impede repositioning of the mobile carboxyl-terminal helix 12, which blocks the ligand-dependent transactivation function (AF-2) located in the AR ligand-binding domain (ARLBD). Using crystal structures of the hARLBD, we first found that H12 could be directly reached from the ligand-binding pocket (LBP) by a chain positioned on the C18 atom of an androgen steroid nucleus. A set of 5alpha-dihydrotestosterone-derived molecules bearing various C18 chains were thus synthesized and tested for their capacity to bind hAR and act as antagonists. Although most of those having very high affinity for hAR were agonists, several very potent antagonists were obtained, confirming the structural importance of the C18 chain. To understand the role of the C18 chain in their agonistic/antagonistic properties, the structure of the hARLBD complexed with one of these agonists, EM5744, was determined at a 1.65-A resolution. We have identified new interactions involving Gln(738), Met(742), and His(874) that explain both the high affinity of this compound and the inability of its bulky chain to prevent the repositioning of H12. This structural information will be helpful to refine the structure of the chains placed on the C18 atom to obtain efficient H12-directed steroidal antiandrogens.
 +
 
 +
==Disease==
 +
Known diseases associated with this structure: Androgen insensitivity OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=313700 313700]], Breast cancer, male, with Reifenstein syndrome OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=313700 313700]], Hypospadias, perineal OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=313700 313700]], Prostate cancer OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=313700 313700]], Prostate cancer, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=313700 313700]], Spinal and bulbar muscular atrophy of Kennedy OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=313700 313700]]
==About this Structure==
==About this Structure==
Line 10: Line 13:
==Reference==
==Reference==
-
Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally-designed steroidal ligand bearing a bulky chain directed toward helix 12., Cantin L, Faucher F, Couture JF, Pereira de Jesus-Tran K, Legrand P, Ciobanu LC, Frechette Y, Labrecque R, Singh SM, Labrie F, Breton R, J Biol Chem. 2007 Aug 21;. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17711855 17711855]
+
Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12., Cantin L, Faucher F, Couture JF, de Jesus-Tran KP, Legrand P, Ciobanu LC, Frechette Y, Labrecque R, Singh SM, Labrie F, Breton R, J Biol Chem. 2007 Oct 19;282(42):30910-9. Epub 2007 Aug 21. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17711855 17711855]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Breton, R.]]
[[Category: Breton, R.]]
[[Category: Cantin, L.]]
[[Category: Cantin, L.]]
-
[[Category: Ciobanu, C.L.]]
+
[[Category: Ciobanu, C L.]]
-
[[Category: Couture, J.F.]]
+
[[Category: Couture, J F.]]
[[Category: Faucher, F.]]
[[Category: Faucher, F.]]
-
[[Category: Jesus-Tran, K.Pereira.de.]]
+
[[Category: Jesus-Tran, K Pereira de.]]
[[Category: Labrie, F.]]
[[Category: Labrie, F.]]
[[Category: Legrand, P.]]
[[Category: Legrand, P.]]
-
[[Category: Singh, S.M.]]
+
[[Category: Singh, S M.]]
[[Category: DTT]]
[[Category: DTT]]
[[Category: ENM]]
[[Category: ENM]]
Line 34: Line 37:
[[Category: ligand binding domain]]
[[Category: ligand binding domain]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 12:33:13 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:31:30 2008''

Revision as of 16:31, 21 February 2008


2pnu, resolution 1.650Å

Drag the structure with the mouse to rotate

Crystal structure of human androgen receptor ligand-binding domain in complex with EM-5744

Contents

Overview

Antiandrogens are commonly used to treat androgen-dependent disorders. The currently used drugs unfortunately possess very weak affinity for the human AR (hAR), thus indicating the need to develop new high-affinity steroidal antiandrogens. Our compounds are specially designed to impede repositioning of the mobile carboxyl-terminal helix 12, which blocks the ligand-dependent transactivation function (AF-2) located in the AR ligand-binding domain (ARLBD). Using crystal structures of the hARLBD, we first found that H12 could be directly reached from the ligand-binding pocket (LBP) by a chain positioned on the C18 atom of an androgen steroid nucleus. A set of 5alpha-dihydrotestosterone-derived molecules bearing various C18 chains were thus synthesized and tested for their capacity to bind hAR and act as antagonists. Although most of those having very high affinity for hAR were agonists, several very potent antagonists were obtained, confirming the structural importance of the C18 chain. To understand the role of the C18 chain in their agonistic/antagonistic properties, the structure of the hARLBD complexed with one of these agonists, EM5744, was determined at a 1.65-A resolution. We have identified new interactions involving Gln(738), Met(742), and His(874) that explain both the high affinity of this compound and the inability of its bulky chain to prevent the repositioning of H12. This structural information will be helpful to refine the structure of the chains placed on the C18 atom to obtain efficient H12-directed steroidal antiandrogens.

Disease

Known diseases associated with this structure: Androgen insensitivity OMIM:[313700], Breast cancer, male, with Reifenstein syndrome OMIM:[313700], Hypospadias, perineal OMIM:[313700], Prostate cancer OMIM:[313700], Prostate cancer, susceptibility to OMIM:[313700], Spinal and bulbar muscular atrophy of Kennedy OMIM:[313700]

About this Structure

2PNU is a Single protein structure of sequence from Homo sapiens with , , and as ligands. Full crystallographic information is available from OCA.

Reference

Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12., Cantin L, Faucher F, Couture JF, de Jesus-Tran KP, Legrand P, Ciobanu LC, Frechette Y, Labrecque R, Singh SM, Labrie F, Breton R, J Biol Chem. 2007 Oct 19;282(42):30910-9. Epub 2007 Aug 21. PMID:17711855

Page seeded by OCA on Thu Feb 21 18:31:30 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools